Modification of strain-specific femoral bone density by bone marrow-derived factors administered neonatally: a study on the spontaneously osteoporotic mouse, SAMP6.
SAMP6 is a recently developed strain of osteoporotic mice, and SAMP2 is a control for SAMP6 and has a higher peak bone mass. The bone mass of SAMP6 was increased until 2 months of age when a lysate of cells derived from the bone marrow of SAMP2 was injected at 1 or 4 days of age, but it was not increased when the lysate was injected at 21 days of age. No effect on bone mass was observed when lysates of other cells, bovine serum albumin or heat-inactivated lysate of bone marrow-derived cells of SAMP2, were injected. The ability to increase bone mass was not in the supernatant but in the pellet obtained by ultracentrifugation (105,000 g) of the lysate of bone marrow-derived cells of SAMP2. The lysate did not change the osteoclast surface but changed the appositional bone formation. In conclusion, the lysate of cells derived from the bone marrow of SAMP2 contains factors which can increase the bone mass of SAMP6, and these factors are present in the pellet obtained by ultracentrifugation.
Takahashi
K
K
Department of Orthopedic Surgery, Faculty of Medicine, Kyoto University, Japan.
Tsuboyama
T
T
Matsushita
M
M
Kasai
R
R
Okumura
H
H
Yamamuro
T
T
Okamoto
Y
Y
Toriyama
K
K
Kitagawa
K
K
Takeda
T
T
D000818:Animals; D000831:Animals, Newborn; D015519:Bone Density; D001846:Bone Development; D001853:Bone Marrow / Q000502:physiology; D001854:Bone Marrow Cells; D003720:Densitometry; D005269:Femur / Q000473:pathology*; D008297:Male; D051379:Mice; D008817:Mice, Mutant Strains; D010010:Osteoclasts / Q000473:pathology; D010024:Osteoporosis / Q000473:pathology*; D013045:Species Specificity; D013752:Tetracycline / Q000378:metabolism
D013752:Tetracycline